Keyphrases
Bone Marrow
100%
Minimal Residual Disease
100%
Patients with Breast Cancer
100%
Lymph Node Sampling
100%
Metastasis
75%
Tumor Cells Detection
75%
Breast Cancer
50%
Prognostic Factors
50%
Node-negative
50%
Bone Marrow Aspiration
50%
High Risk
25%
Treatment Monitoring
25%
Gene Therapy
25%
Tumor Cells
25%
Overall Survival
25%
Epithelial Cells
25%
Disease-free Survival
25%
Clinical Application
25%
Lymph Node Involvement
25%
Axillary Lymph Node
25%
Small Tumor
25%
Disease Course
25%
Disease-specific
25%
Target Organ
25%
Clinical Signs
25%
New Treatment Options
25%
Molecular Biology Techniques
25%
Cytoreduction
25%
Specific Marker
25%
Lymph Node Dissection
25%
Individual Cells
25%
Sentinel Lymph Node Biopsy
25%
Metastatic Potential
25%
Primary Breast Cancer
25%
Marker Genes
25%
Cellular Dormancy
25%
PCR Technology
25%
Axillary Nodes
25%
Gene Immunotherapy
25%
Media Groups
25%
Adjuvant Systemic Therapy
25%
Biological Detection
25%
Immunocytology
25%
Axillary Lymph Node Status
25%
Diagnostic Spectrum
25%
Medicine and Dentistry
Lymph Node
100%
Breast Cancer
100%
Minimal Residual Disease
100%
Tumor Cell
80%
Metastatic Carcinoma
60%
Axillary Lymph Node
40%
Prognostic Factor
40%
Bone Marrow Biopsy
40%
Diseases
40%
Diagnosis
20%
Neoplasm
20%
Overall Survival
20%
Immunotherapy
20%
Epithelial Cell
20%
Gene Therapy
20%
Retroperitoneal Lymph Node Dissection
20%
Disease Free Survival
20%
Adjuvant Therapy
20%
Skeleton
20%
Biopsy Technique
20%
Metastasis Potential
20%
Target Organ
20%
Sentinel Node
20%
Immunocytochemistry
20%
Marker Gene
20%
Dormancy
20%
Immunology and Microbiology
Tumor Cell
100%
Lymph Node
100%
Axillary Lymph Node
50%
Overall Survival
25%
Disease Free Survival
25%
Immunotherapy
25%
Target Organ
25%
Immunocytochemistry
25%
Skeleton
25%
Marker Gene
25%
Dormancy
25%